Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.

Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)-denervated striatum after 6-hydroxydopamine-induced destruction of the nig...

Full description

Bibliographic Details
Main Authors: Jean Lud Cadet, Christie Brannock, Irina N Krasnova, Bruce Ladenheim, Michael T McCoy, Jenny Chou, Elin Lehrmann, William H Wood, Kevin G Becker, Yun Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-12-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3001483?pdf=render
_version_ 1818050007604920320
author Jean Lud Cadet
Christie Brannock
Irina N Krasnova
Bruce Ladenheim
Michael T McCoy
Jenny Chou
Elin Lehrmann
William H Wood
Kevin G Becker
Yun Wang
author_facet Jean Lud Cadet
Christie Brannock
Irina N Krasnova
Bruce Ladenheim
Michael T McCoy
Jenny Chou
Elin Lehrmann
William H Wood
Kevin G Becker
Yun Wang
author_sort Jean Lud Cadet
collection DOAJ
description Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)-denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (±1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side.
first_indexed 2024-12-10T10:46:38Z
format Article
id doaj.art-e11e909f60e946068f603bde0da19702
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T10:46:38Z
publishDate 2010-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e11e909f60e946068f603bde0da197022022-12-22T01:52:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-12-01512e1564310.1371/journal.pone.0015643Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.Jean Lud CadetChristie BrannockIrina N KrasnovaBruce LadenheimMichael T McCoyJenny ChouElin LehrmannWilliam H WoodKevin G BeckerYun WangUnilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)-denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (±1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side.http://europepmc.org/articles/PMC3001483?pdf=render
spellingShingle Jean Lud Cadet
Christie Brannock
Irina N Krasnova
Bruce Ladenheim
Michael T McCoy
Jenny Chou
Elin Lehrmann
William H Wood
Kevin G Becker
Yun Wang
Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
PLoS ONE
title Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
title_full Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
title_fullStr Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
title_full_unstemmed Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
title_short Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
title_sort methamphetamine induced dopamine independent alterations in striatal gene expression in the 6 hydroxydopamine hemiparkinsonian rats
url http://europepmc.org/articles/PMC3001483?pdf=render
work_keys_str_mv AT jeanludcadet methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT christiebrannock methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT irinankrasnova methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT bruceladenheim methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT michaeltmccoy methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT jennychou methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT elinlehrmann methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT williamhwood methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT kevingbecker methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats
AT yunwang methamphetamineinduceddopamineindependentalterationsinstriatalgeneexpressioninthe6hydroxydopaminehemiparkinsonianrats